Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of Second COVID-19 Booster in Chinese Adults
NCT05855408Phase 4Unknown
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- May 2023
- Primary completion
- May 2024
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics, Viral Vectors
- Countries
- 1
01
Overview
A Phase 4 trial of ad5-ncov, Pneucolin, SYS6006 in coronavirus disease 2019 (COVID-19), sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Status: unknown.
02
Drugs
ad5-ncovPneucolinSYS6006
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05855408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05855408.